U.S. drugmaker Eli Lilly and Co said it was “deeply concerned” about allegations published in a Chinese newspaper that it spent more than 30 million yuan ($4.90 million) to bribe doctors in China to prescribe the firm’s medicines instead of rival products. A former senior manager for the company, identified by the pseudonym Wang Wei, told the 21st Century Business Herald that bribery and illegal payments at Eli Lilly’s China operations were widespread, the paper reported on Thursday. Eli Lilly is the third foreign drugmaker to face whistleblower accusations in the newspaper this month.
Help employers find you! Check out all the jobs and post your resume.
